Targeting therapeutic and imaging agents to folate receptor positive tumors.
about
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Folic acid conjugated δ-valerolactone-poly(ethylene glycol) based triblock copolymer as a promising carrier for targeted doxorubicin deliveryRational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Self-assembled lipid nanomedicines for siRNA tumor targeting.The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting.New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersFolate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse modelDual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment.The importance of chemistry in creating well-defined nanoscopic embedded therapeutics: devices capable of the dual functions of imaging and therapy.Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cellsEndothelial cells and macrophages, partners in atherosclerotic plaque progression.Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy.Optical tecnology developments in biomedicine: history, current and futurePoly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.Folate receptor alpha as a tumor target in epithelial ovarian cancerFolic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers.Nanomedicine: de novo design of nanodrugs.Hierarchical layered double hydroxide nanocomposites: structure, synthesis and applications.Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.Multifunctional nanoassemblies of block copolymers for future cancer therapy.Bimodal perfluorocarbon nanoemulsions for nasopharyngeal carcinoma targeting.A galactosidase-responsive "trojan horse" for the selective targeting of folate receptor-positive tumor cells.Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy.Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy.Clinical application of a rapid cervical cancer screening method: Folate receptor-mediated staining of cervical neoplastic epithelia.Highly Luminescent Folate-Functionalized Au22 Nanoclusters for Bioimaging.Folate-decorated arginine-based poly(ester urea urethane) nanoparticles as carriers for gambogic acid and effect on cancer cells.Folic-Acid-Modified Conducting Polymer: Electrochemical Detection of the Cell Attachment.Folic acid conjugated magnetic drug delivery system for controlled release of doxorubicinPreparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Cisplatin
P2860
Q28078448-8AA9D4CE-FFA8-482C-84C1-23498F2FC542Q28535478-109EEE1A-8A6F-4F9F-9061-668C09E0AF96Q30436623-CCEFBBEE-BAFB-4E2C-AC50-4354FA91A7F2Q33230098-5654DC18-E70E-41DD-ADDD-64F274BDDDFCQ33907953-74430597-C1C8-4EFD-9B10-9B0DEACF005DQ34108716-93A07269-53BA-42ED-A199-FAEFAA3D59E1Q34590348-D44BF863-D53C-4EFE-ACD7-9BCDF25F8094Q34706060-00AB23A7-DE67-4205-9212-831A9F56453CQ35057527-54B8AC5A-5ABF-4C16-AB03-955D353E13F9Q35236160-31CBF6C6-986B-486A-893D-85ECB17478DFQ35388548-D834BB2F-E515-4614-ABBD-F8307D708573Q36093923-195BFA61-1179-4D88-96FC-694136CA3ED0Q36197710-A3AE4F34-E2C7-4AA1-850F-CD50D49DE10EQ36409038-52760099-8628-4BBF-B7BE-616B7A45961CQ36540861-CE56365E-7560-4536-A9EC-0276CCD7F22AQ36687950-D28DC998-792E-490E-8D5A-8CB72885592CQ36781046-2F4219BA-EBC4-429F-B287-FE0D52AEC468Q37058474-ECA2A3E0-E03F-463B-9AB4-235CCAEF2B22Q37121790-E41A7EB5-18D0-4084-BD00-443F30646A72Q37254805-38882A3A-AAFD-47B9-AA30-783A36DCF992Q37300767-D15CD522-5CDF-4472-995D-EE53DFE110E2Q38074461-0876E64C-2861-4358-B6DA-517548001AE0Q38168683-542B311D-4809-4EA9-89DB-11B27959D224Q38308693-5D9EB23B-A373-4954-8B2F-94BAFF27FFF0Q38309549-7E45610F-5D8A-469D-87A5-0B35063DD5D4Q39017324-F967A5E1-5024-4DCC-B160-E5E373CA0D5AQ39178816-E369DBAC-986C-4FCD-99A7-D9465EFD5BE9Q39569531-19813222-CF65-4602-9E3D-1836E1403AD6Q41103685-905D5FF7-0D4A-42E4-A8B3-68E669F2FE7CQ42528833-2124FD3E-D5B7-4FD8-8151-A27AA265D91AQ44453117-71DFB9AB-457B-491F-8236-89B6929BB279Q50196523-9298B57B-6647-4D3D-BA41-A80A3657413EQ50647671-FB69E894-8D3D-47C3-BB76-17400AF12853Q51116566-22A70037-9829-4501-9EA4-71330F8CAB4CQ51605414-0E6AF094-9E4C-48AC-8C08-1AB8FAB2A08CQ57355687-A76E912F-D527-42B6-A614-9C472A783D61Q58910111-CB9BFBB7-3843-40B8-A686-56B209DE4C99
P2860
Targeting therapeutic and imaging agents to folate receptor positive tumors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@ast
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@en
type
label
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@ast
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@en
prefLabel
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@ast
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@en
P2093
P356
P1476
Targeting therapeutic and imaging agents to folate receptor positive tumors.
@en
P2093
P304
P356
10.2174/1389201053642376
P577
2005-04-01T00:00:00Z